MENU
QNCX
AS OF
Dec 24 closing price
Price
$3.66
Change
-$0.01 (-0.27%)
Capitalization
203.79M
68 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
QNCX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Quince Therapeutics (QNCX) Ownership - Who owns Quince Therapeutics?

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 415 910-5717
Employees
32
Web
https://www.quincetx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
203.79M
P/E Ratio
N/A
Total Cash
26.29M
Projected Growth
N/A
Total Debt
17.99M
Revenue
N/A
Risk (Beta)
1.02
Dividend Yield
N/A
Total Cash/Share
0.47
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

QNCX
Capitalization
204M
P/E Ratio
N/A
Risk (Beta)
1.02
Dividend Yield
N/A
Total Cash
26.3M
Total Cash/Share
0.47
Total Debt
18M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.06M
P/B Ratio
192.31
Cash Flow
N/A
Earnings
-1.2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54K
Current Ratio
1.12
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-44.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.20
Shares Held By Institutions
22.5M
Shares Outstanding - Current
55.7M
Total Liabilities
109M
Total Volume MTD
N/A
Value
-1
Gain YTD
95.722
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
QNCX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. QNCX showed earnings on November 13, 2025. You can read more about the earnings report here.
View AI-Driven Trading for QNCX
A.I. Advisor
published General Information

General Information

a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 415 910-5717
Employees
32
Web
https://www.quincetx.com